Apollo Global Management, Inc. filed a Free Writing Prospectus on November 9, 2026, disclosing the final pricing terms for a $600,000,000 offering of 7.550% Fixed-Rate Resettable Junior Subordinated Notes due 2056.
Brian Valania, CEO and CFO of Mitesco, Inc., filed a Form 4 on November 9, 2026, disclosing multiple acquisitions of common stock and Series X Preferred Stock across transactions dated from July 29, 2024 through November 5, 2026.
Christopher James Stevens, an officer of Rocket Pharmaceuticals, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 16,131 shares of common stock on NASDAQ under Rule 144 of the Securities Act of 1933.
JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) fact sheet on November 9, 2026, disclosing terms for Market Linked Securities auto-callable with leveraged upside participation and contingent downside, linked to the lowest performing of the S&P 500 Index and the Dow …
Astera Labs, Inc. director Stefan A. Dyckerhoff filed an amended Form 144 notice on November 9, 2026, disclosing a proposed sale of 12,499 shares of Astera Labs common stock with an approximate sale date of November 5, 2026, through broker Stifel Nicolaus & Company …
United Airlines Holdings, Inc. officer Kate Gebo filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 28,283 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ:UAL.
Sarbani Chaudhuri, an officer of Rocket Pharmaceuticals, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 4,872 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ:RCKT.
William O'Dowd IV, Chief Executive Officer and director of Dolphin Entertainment, Inc., filed a Form 4 on November 9, 2026, disclosing an open-market purchase of 5,200 shares of common stock pursuant to a Rule 10b5-1 trading plan.
A Form 144 notice of proposed sale of United Airlines Holdings, Inc. common stock was filed on November 9, 2026, on behalf of Kate Gebo, identified as a member of the immediate family of an officer of the issuer.
Orange County Bancorp, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting third-quarter and year-to-date financial results for the company listed on NASDAQ:OBT.